vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Gaotu Techedu Inc. (GOTU). Click either name above to swap in a different company.

Gaotu Techedu Inc. is the larger business by last-quarter revenue ($767.1M vs $749.2M, roughly 1.0× CLOVER HEALTH INVESTMENTS, CORP.). Over the past eight quarters, Gaotu Techedu Inc.'s revenue compounded faster (141.9% CAGR vs 45.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Gaotu Techedu Inc. is a Chinese education technology company offering online tutoring services for K-12 students, along with foreign language and professional training courses for adults. The company was founded in 2014 by Xiang Dong Chen. Its primary product is the online education platform Genshuixue.

CLOV vs GOTU — Head-to-Head

Bigger by revenue
GOTU
GOTU
1.0× larger
GOTU
$767.1M
$749.2M
CLOV
Faster 2-yr revenue CAGR
GOTU
GOTU
Annualised
GOTU
141.9%
45.0%
CLOV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
GOTU
GOTU
Revenue
$749.2M
$767.1M
Net Profit
$27.3M
Gross Margin
Operating Margin
3.6%
Net Margin
3.6%
Revenue YoY
62.0%
Net Profit YoY
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GOTU
GOTU
Q1 26
$749.2M
Q4 25
$487.7M
$767.1M
Q3 25
$496.6M
$221.8M
Q2 25
$477.6M
$194.0M
Q1 25
$462.3M
$205.7M
Q4 24
$337.0M
$318.7M
Q3 24
$331.0M
$172.2M
Q2 24
$356.3M
$139.0M
Net Profit
CLOV
CLOV
GOTU
GOTU
Q1 26
$27.3M
Q4 25
$-49.3M
Q3 25
$-24.4M
$-20.7M
Q2 25
$-10.6M
$-30.2M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
$-59.1M
Gross Margin
CLOV
CLOV
GOTU
GOTU
Q1 26
Q4 25
Q3 25
66.1%
Q2 25
66.0%
Q1 25
69.7%
Q4 24
Q3 24
24.5%
64.4%
Q2 24
30.3%
69.0%
Operating Margin
CLOV
CLOV
GOTU
GOTU
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
-11.3%
Q2 25
-2.2%
-17.4%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
-46.0%
Net Margin
CLOV
CLOV
GOTU
GOTU
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
-9.3%
Q2 25
-2.2%
-15.5%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
-42.5%
EPS (diluted)
CLOV
CLOV
GOTU
GOTU
Q1 26
$0.05
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GOTU
GOTU
Cash + ST InvestmentsLiquidity on hand
$177.6M
$596.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
$1.3B
Total Assets
$697.7M
$6.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GOTU
GOTU
Q1 26
$177.6M
Q4 25
$78.3M
$596.2M
Q3 25
$318.7M
Q2 25
$814.4M
Q1 25
$1.0B
Q4 24
$194.5M
$433.8M
Q3 24
$288.0M
$855.8M
Q2 24
$254.8M
$1.4B
Stockholders' Equity
CLOV
CLOV
GOTU
GOTU
Q1 26
$339.4M
Q4 25
$308.7M
$1.3B
Q3 25
$340.9M
$1.4B
Q2 25
$344.2M
$1.6B
Q1 25
$336.1M
$1.9B
Q4 24
$341.1M
$264.9M
Q3 24
$342.2M
$2.1B
Q2 24
$324.9M
$2.7B
Total Assets
CLOV
CLOV
GOTU
GOTU
Q1 26
$697.7M
Q4 25
$541.0M
$6.2B
Q3 25
$559.7M
$5.1B
Q2 25
$575.0M
$5.9B
Q1 25
$583.7M
$5.2B
Q4 24
$580.7M
$798.4M
Q3 24
$653.0M
$5.2B
Q2 24
$674.2M
$5.8B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons